peptide-radioisotope conjugates

Genentech PeptiDream peptide deal, Peptide-radioisotope drug conjugates, Peptide discovery platform system, Genentech Roche radiopharmaceuticals, PeptiDream PDPS technology, Genentech cancer targets, PeptiDream milestone payments,

Genentech and PeptiDream expand peptide collaboration to explore radiopharmaceuticals for cancer

Anika Sharma

Japanese biotech firm PeptiDream continues to attract significant interest from major pharmaceutical companies. Genentech, a long-term partner, has entered into ...